Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit A crackdown on corruption in China’s pharmaceutical sector has hurt sales at international and… by InvestAdvocate — September 18, 2013 in Uncategorized
Nigeria’s Oando falls for a second day on Ibori allegations Shares in Nigerian oil company Oando fell by almost the 10 percent limit allowed on… by InvestAdvocate — September 18, 2013 in Uncategorized
U.S. poverty rises despite economic recovery The number of U.S. residents living in poverty edged up to 46.5 million last year,… by InvestAdvocate — September 18, 2013 in Uncategorized